enVVeno Medical Corp Increase Decrease In Operating Lease Liability
enVVeno Medical Corp (NVNO) reported Increase Decrease In Operating Lease Liability of -$195.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-30
- enVVeno Medical Corp increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$98.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$97.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$91.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$91.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for fiscal 2025 was -$364.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for fiscal 2024 was -$338.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for fiscal 2023 was -$314.00K.
- enVVeno Medical Corp increase decrease in operating lease liability for fiscal 2022 was -$290.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$195.00K 10-Q · filed 2026-07-30 | -$286.00K derived: sum of 3 quarters · filed 2026-07-30 | -$377.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$97.00K 10-Q · filed 2026-05-06 | -$188.00K derived: sum of 2 quarters · filed 2026-05-06 | -$279.00K derived: sum of 3 quarters · filed 2026-05-06 | -$376.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$182.00K derived: sum of 2 quarters · filed 2026-03-26 | -$279.00K derived: sum of 3 quarters · filed 2026-07-30 | -$364.00K 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$188.00K derived: sum of 2 quarters · filed 2026-07-30 | -$273.00K 10-Q · filed 2025-10-30 | -$357.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$182.00K 10-Q · filed 2026-07-30 | -$266.00K derived: sum of 3 quarters · filed 2026-07-30 | -$351.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$85.00K 10-Q · filed 2026-05-06 | -$169.00K derived: sum of 2 quarters · filed 2026-05-06 | -$254.00K derived: sum of 3 quarters · filed 2026-05-06 | -$338.00K derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$169.00K derived: sum of 2 quarters · filed 2026-03-26 | -$253.00K derived: sum of 3 quarters · filed 2026-03-26 | -$338.00K 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$169.00K derived: sum of 2 quarters · filed 2025-10-30 | -$254.00K 10-Q · filed 2025-10-30 | -$332.00K derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | -$84.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$169.00K 10-Q · filed 2025-07-31 | -$247.00K derived: sum of 3 quarters · filed 2025-07-31 | -$326.00K derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | -$85.00K 10-Q · filed 2025-04-30 | -$163.00K derived: sum of 2 quarters · filed 2025-04-30 | -$242.00K derived: sum of 3 quarters · filed 2025-04-30 | -$320.00K derived: sum of 4 quarters · filed 2025-04-30 | ||||
| 2023-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$157.00K derived: sum of 2 quarters · filed 2025-02-28 | -$235.00K derived: sum of 3 quarters · filed 2025-02-28 | -$314.00K 10-K · filed 2025-02-28 | ||||
| 2023-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$157.00K derived: sum of 2 quarters · filed 2024-10-31 | -$236.00K 10-Q · filed 2024-10-31 | -$309.00K derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$157.00K 10-Q · filed 2024-07-31 | -$230.00K derived: sum of 3 quarters · filed 2024-07-31 | -$302.00K derived: sum of 4 quarters · filed 2024-07-31 | ||||
| 2023-03-31 | -$79.00K 10-Q · filed 2024-05-08 | -$152.00K derived: sum of 2 quarters · filed 2024-05-08 | -$224.00K derived: sum of 3 quarters · filed 2024-05-08 | -$297.00K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$145.00K derived: sum of 2 quarters · filed 2024-02-29 | -$218.00K derived: sum of 3 quarters · filed 2024-02-29 | -$290.00K 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$145.00K derived: sum of 2 quarters · filed 2023-10-26 | -$217.00K 10-Q · filed 2023-10-26 | -$295.00K derived: sum of 4 quarters · filed 2023-10-26 | ||||
| 2022-06-30 | -$73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | -$145.00K 10-Q · filed 2023-07-31 | -$223.00K derived: sum of 3 quarters · filed 2023-07-31 | -$301.00K derived: sum of 4 quarters · filed 2023-07-31 | ||||
| 2022-03-31 | -$72.00K 10-Q · filed 2023-04-28 | -$150.00K derived: sum of 2 quarters · filed 2023-04-28 | -$228.00K derived: sum of 3 quarters · filed 2023-04-28 | -$306.00K derived: sum of 4 quarters · filed 2023-04-28 | ||||
| 2021-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$156.00K derived: sum of 2 quarters · filed 2023-03-02 | -$234.00K derived: sum of 3 quarters · filed 2023-03-02 | -$313.00K 10-K · filed 2023-03-02 | -$312.61K 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$156.00K derived: sum of 2 quarters · filed 2022-10-27 | -$235.00K 10-Q · filed 2022-10-27 | -$235.65K 10-Q · filed 2021-11-12 | -$307.17K derived: sum of 4 quarters · filed 2022-10-27 | |||
| 2021-06-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$157.00K 10-Q · filed 2022-08-03 | -$157.10K 10-Q · filed 2021-08-11 | -$229.17K derived: sum of 3 quarters · filed 2022-08-03 | -$301.34K derived: sum of 4 quarters · filed 2022-08-03 | |||
| 2021-03-31 | -$79.00K 10-Q · filed 2022-04-29 | -$78.55K 10-Q · filed 2021-05-12 | -$151.17K derived: sum of 2 quarters · filed 2022-04-29 | -$223.34K derived: sum of 3 quarters · filed 2022-04-29 | -$301.38K derived: sum of 4 quarters · filed 2022-04-29 | |||
| 2020-12-31 | -$72.17K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$144.34K derived: sum of 2 quarters · filed 2022-03-28 | -$222.38K derived: sum of 3 quarters · filed 2022-03-28 | -$288.69K 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | -$72.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$150.20K derived: sum of 2 quarters · filed 2021-11-12 | -$216.51K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$78.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$144.34K 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | -$66.31K 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |